Diseases, Conditions, Syndromes

Radavirsen performs well in early influenza trial

A phase 1 clinical trial published in the British Journal of Clinical Pharmacology found that radavirsen—an antisense oligomer that inhibits the production of certain influenza proteins—is safe and well-tolerated in healthy ...

Oncology & Cancer

Strategies compared for cancer medication submission lags

(HealthDay)—For development of oncology drugs in Japan, the global trial (GT) strategy and early-initiation bridging (BG) strategy are associated with shorter submission lag (SL) than late-initiation BG strategy, according ...

Diseases, Conditions, Syndromes

Intravenous lidocaine offers alternative for ICU patients' pain

(HealthDay)—Intravenous lidocaine (IVLI) seems safe for reducing pain among patients in the intensive care unit (ICU) with varying degrees of organ dysfunction, according to research published online Feb. 7 in the Journal ...

Diseases, Conditions, Syndromes

Antibiotic gel prevents borreliosis resulting from tick bites

An antibiotic gel based on azithromycin, an antibiotic with antibacterial properties, helps to prevent the onset of Lyme borreliosis following a tick bite. That is the finding of a multi-centre international study, in which ...

Cardiology

Review: 5-HT3 receptor antagonists cut peri-op shivering

(HealthDay)—5-HT3 receptor antagonists (5-HT3RAs) seem to be effective for preventing perioperative shivering (POS), according to a review and meta-analysis published online Sept. 15 in the Journal of Clinical Pharmacology.

page 6 from 13